SCHEMBL88058

SCHEMBL88058

O=C1c2ccccc2-c2ccc3c4ccc5c6c(ccc(c7ccc1c2c73)c64)-c1ccccc1C5=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 2/20 0.60
CYP3A4 P08684 3/20 0.59
DNMT1 P26358 3/20 0.59
PABPC1 P11940 2/20 0.59
CASP1 P29466 1/20 0.59
CASP7 P55210 1/20 0.59
SMN1; SMN2 Q16637 4/20 0.58
KDM4E B2RXH2 2/20 0.58
MAPT P10636 2/20 0.58
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
CDC25B P30305 1/20 0.55
CYP1A2 P05177 4/20 0.53
HIF1A Q16665 2/20 0.53
HSD17B10 Q99714 1/20 0.53
S100A4 P26447 4/20 0.52
PTPRC P08575 4/20 0.52
MAPK1 P28482 3/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12031457 1.00 BCL2 (0.60) BCL2CYP3A4DNMT1PABPC1CASP1
Anthraquinone SCHEMBL4307959 1.00 BCL2 (0.60) BCL2CYP3A4DNMT1PABPC1CASP1
SCHEMBL79475 1.00 BCL2 (0.60) BCL2CYP3A4DNMT1PABPC1CASP1
SCHEMBL29354334 1.00 BCL2 (0.60) BCL2CYP3A4DNMT1PABPC1CASP1
SCHEMBL12449237 1.00 BCL2 (0.60) BCL2CYP3A4DNMT1PABPC1CASP1
SCHEMBL29356917 1.00 BCL2 (0.60) BCL2CYP3A4DNMT1PABPC1CASP1
Bromide SCHEMBL28387245 0.98 BCL2 (0.58) BCL2CYP3A4DNMT1PABPC1CASP1
SCHEMBL5072170 0.91 DNMT1 (0.70) BCL2CYP3A4DNMT1PABPC1CASP1
SCHEMBL31500772 0.91 DNMT1 (0.70) BCL2CYP3A4DNMT1PABPC1CASP1
SCHEMBL43327 0.91 DNMT1 (0.70) BCL2CYP3A4DNMT1PABPC1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0073007-B1 METHOD FOR THE SQUARE DIMENSIONAL CONCENTRATION OF LIGHT, AND FLUORESCENT COMPOUNDS BASF Aktiengesellschaft (DE) 1984-12-27 EP claimed
US-20240219366-A1 A METHOD OF DETECTING ONE OR MORE MARKERS IN A PETROLEUM FUEL USING A PHOTOACOUSTIC DETECTOR BASF SCHWEIZ AG (CH) 2024-07-04 US disclosed
EP-2776516-B1 POLYMER BONDED VAT DYES SICPA HOLDING SA (CH) 2022-12-28 EP disclosed
US-11220583-B2 Block copolymer, ion-exchange membrane and method of preparing block copolymer KOREA INSTITUTE OF ENERGY RESEARCH (KR) 2022-01-11 US disclosed
US-20210255561-A1 LIQUID ELECTROPHOTOGRAPHIC INK COMPOSITION HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2021-08-19 US disclosed
US-10962696-B2 Coatable grey polarizer LIGHT POLYMERS HOLDING (KY) 2021-03-30 US disclosed
US-20200299475-A1 BLOCK COPOLYMER, ION-EXCHANGE MEMBRANE AND METHOD OF PREPARING BLOCK COPOLYMER KOREA INSTITUTE OF ENERGY RESEARCH (KR) 2020-09-24 US disclosed
US-10717835-B2 Block copolymer, ion-exchange membrane and method of preparing block copolymer KOREA INSTITUTE OF ENERGY RESEARCH (KR) 2020-07-21 US disclosed
US-20190235144-A1 COATABLE GREY POLARIZER LIGHT POLYMERS HOLDING (KY) 2019-08-01 US disclosed
US-20180134844-A1 Block Copolymer, Ion-Exchange Membrane And Method Of Preparing Block Copolymer KOREA INSTITUTE OF ENERGY RESEARCH (KR) 2018-05-17 US disclosed
US-20070210322-A1 Light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-09-13 US disclosed
US-20070210322-A1 Light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-09-13 US disclosed
EP-1833104-A2 Light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-09-12 EP disclosed
US-20070051275-A1 Method of colouring carrier materials CIBA SPECIALTY CHEMICALS CORP. 2007-03-08 US disclosed
US-20070051275-A1 Method of colouring carrier materials CIBA SPECIALTY CHEMICALS CORP. 2007-03-08 US disclosed
US-20030127040-A1 Residual Life Indicator SCENTCZAR CORPORATION 2003-07-10 US disclosed
US-6563556-B2 Photoluminescent layer with dichroically absorbing color agent and isotropic emitting color agent; luminous efficacy KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2003-05-13 US disclosed
US-20010033348-A1 Liquid crystal color picture screen KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2001-10-25 US disclosed
EP-1136871-A2 Colour liquid crystal display device Philips Patentverwaltung GmbH (DE) 2001-09-26 EP disclosed
US-4486587-A LIGHFASTNESS, THEROMOSTABILITY BASF AKTIENGESELLSCHAFT (DE) 1984-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190235144-A1 COATABLE GREY POLARIZER MAPK12, MARK4, RCC2 BCL2 4717/4885CYP3A4 749/4885DNMT1 950/4885
US-10962696-B2 Coatable grey polarizer MAPK12, MARK4, RCC2 BCL2 4717/4885CYP3A4 749/4885DNMT1 950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.